The Canadian Children Inflammatory Bowel Disease Network
.png/:/rs=w:365,cg:true,m)
Canada has some of the highest rates of childhood IBD in the world, and they continue to climb.
Funded by The C.H.I.L.D. Foundation, CIDsCaNN was developed to provide a collaborative environment involving major IBD centres across Canada.
Funded by The C.H.I.L.D. Foundation, CIDsCaNN was developed to provide a collaborative environment involving major IBD centres across Canada.
.png/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:365,cg:true)
Funded by The C.H.I.L.D. Foundation, CIDsCaNN was developed to provide a collaborative environment involving major IBD centres across Canada.
Funded by The C.H.I.L.D. Foundation, CIDsCaNN was developed to provide a collaborative environment involving major IBD centres across Canada.
Funded by The C.H.I.L.D. Foundation, CIDsCaNN was developed to provide a collaborative environment involving major IBD centres across Canada.
Are you a physician, scientist, health care provider or allied health professional interested in contributing to the CIDsCaNN network?
Funded by The C.H.I.L.D. Foundation, CIDsCaNN was developed to provide a collaborative environment involving major IBD centres across Canada.
Are you a physician, scientist, health care provider or allied health professional interested in contributing to the CIDsCaNN network?
CIDsCaNN Letter to the FDA
Response from CIDsCaNN to the US FDA Draft Guidance for Industry on pediatric IBD: developing drugs
In recent decades, we’ve made big strides in treating children with Inflammatory Bowel Diseases (IBD), but there are still major hurdles to overcome. While IBD is most often diagnosed in adults, the fastest-growing incidence is in children, especially young ones. Furthermore, the disease tends to be more severe in children. Despite this, children who need new treatments the most are often left behind due to delays in approving medications for pediatric use.
Participating CIDsCaNN Member Sites
Participating CIDsCaNN member sites
